Editorials

New antidepressants for old people?

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7199.1640 (Published 19 June 1999) Cite this as: BMJ 1999;318:1640

The evidence that newer drugs are much better than the old is thin

  1. Martin G Livingston, Senior lecturer in psychological medicine ([email protected]),
  2. Hilary M Livingston, Consultant psychiatrist
  1. Southern General Hospital, Glasgow G 51 4TF

    Depression is common in elderly people. Old people are at greater risk of developing adverse events while taking any medication—including antidepressants—because of concurrent illness, consumption of other prescribed and over the counter drugs, dose miscalculation because of forgetfulness, and altered drug kinetics.1 The efficacy and safety of antidepressants in elderly people is therefore an important treatment issue. In all age groups the use of tricyclic antidepressants for depression has been declining in favour of serotonin reuptake inhibitors.2 Although views differ on whether serotonin reuptake inhibitors should be used as first line treatment in depression,3 the drop out rates from treatment are similar for both classes of drug—about a third in each group.4 What is the evidence for efficacy and safety of serotonin reuptake inhibitors and other newer classes of antidepressants drugs inelderly depressed patients?

    Newer, non-tricyclic antidepressants are often claimed to be as effective as but …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe